Greg Lovins
Analyst · Robert W. Baird & Co. Please go ahead
Thanks, and hello, everyone. As Mitch said, we delivered another solid quarter with adjusted earnings per share of $1.72, in line with our expectations, and again up more than 10% on a constant currency basis. We grew sales by 1.6% on an organic basis and currency translation reduced reported sales growth by 4.7 points in the quarter. Adjusted operating margin increased by 60 basis points to 12.1%. And we realized $12 million of restructuring savings, net of transition costs in the quarter. The LGM restructuring in Europe was largely completed as of the end of Q2, which will drive a significant uptick in savings from this initiative in the second half. Turning to cash generation and allocation. Year-to-date, we generated $165 million of free cash flow, up nearly $38 million compared to the prior year. And as we've discussed, we've increased our pace of fixed capital in IT-related spending for two to three-year period to support our long-term organic growth and margin expansion plans, with capital spending expected to be up by about $25 million this year. We continue to expect capital spending then to moderate from this level over the next couple of years, consistent with our long-term capital allocation strategy. And we continue to return cash to shareholders. In the first half of the year, we repurchased roughly 1.2 million shares at an aggregate cost of $117 million. We paid $93 million in dividends, including the 12% increase in the dividend rate in April, for a total of $209 million of cash return to shareholders, up 11% compared to the same period last year. And our balance sheet remains strong. Our current leverage position gives us ample capacity to continue executing our disciplined capital allocation strategy, including investing in organic growth and acquisitions while continuing to return cash to shareholders. We are well positioned to take advantage of any dislocations in the market should they occur over the next few years. I'll now turn to the segment results for the quarter. Label and Graphic Materials sales increased by 0.9% on an organic basis, driven by prior year pricing actions as volume declined modestly. Growth in LGM's high-value categories continued to outpace the growth of the base business, once again led by specialty and durables, which were collectively up high single digits on an organic basis. Breaking down LGM's organic growth in the quarter by region. Both North America and Western Europe declined at low single digit rates, reflecting the market dynamics already discussed. Emerging markets grew at a low single digit rate with China up low single digits and South Asia up high single digits. Adjusted operating margin for the segment was strong at 13.8%, in line with the same period last year, reflecting the benefit of productivity actions including material reengineering, partially offset by currency-related headwinds and the impact of lower volume. As I mentioned in last quarter's call, we've covered the cumulative effect of the roughly 18 months of raw material cost inflation that we experienced through a combination of pricing actions and material reengineering. We're now seeing some modest deflation in our raw material input costs on a sequential basis with comparable sequential declines in both the first and second quarters of the year. Shifting now to Retail Branding and Information Solutions. RBIS delivered solid top line growth, up 4.4% on an organic basis, driven by faster growth in high-value categories with sales of both RFID and external embellishments up more than 20% for the quarter. Our base business was roughly flat, adjusting for the impact of cannibalization due to RFID. Adjusted operating margin for the segment expanded by 130 basis points to 12.5% as productivity and higher volume more than offset higher employee-related costs and growth related investments. Turning to the Industrial and Healthcare Materials segment. Sales were flat on an organic basis, driven by the decline in global auto production as automotive applications globally represent about a third of IHM's sales. Outside of automotive, industrial categories were up mid-single digits on an organic basis. Healthcare categories likewise grew at a mid-single digit pace with better than 20% growth in medical applications. We continue to make good progress on the margin front in IHM. Adjusted operating margin increased by 120 basis points to 10.5% driven by productivity and a net benefit of pricing and raw material costs, which more than offset higher employee-related costs. Gains on the pricing side largely relate to strategic adjustments we made as a result of our work to more effectively segment our portfolio. Focusing now on our outlook for 2019. We have maintained our guidance midpoint for adjusted earnings per share while tightening the range to $6.50 to $6.65. We have reduced our outlook for organic sales growth to a range of 2% to 2.5% in light of the slower market conditions in LGM during the first half that we assume will continue. We have outlined some of the other key contributing factors to this guidance on slide nine of our supplemental presentation materials, in particular, and just focusing on the changes from our assumptions in April. At recent exchange rates, currency translation represents a roughly 2.5-point headwind to reported sales growth for the year with a pre-tax operating income hit of $28 million. This is up slightly from the $27 million we had anticipated previously. We now estimate that incremental pre-tax savings from restructuring, net of transition cost, will contribute about $45 million to $50 million, up $5 million from our April estimate, as we've accelerated a number of actions that were in the pipeline, we've already realized about $17 million in net savings year-to-date and expect the balance of our full-year savings will be split roughly equally between the third and fourth quarters. And we've narrowed our range on average share count, assuming dilution of 84.5 million to 85 million shares reflecting an assumed pick-up from the Q2 pace of share buyback during the second half. In summary, we delivered another solid quarter in a more challenging environment, and we are confident in our ability to deliver the earnings guidance we communicated at the start of the year and are on track to deliver on our long-term objectives to achieve GDP plus growth and top-quartile returns on capital, driving sustained growth in EVA. Now, we'll open up the call for your questions.